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Abstract. Recent randomised clinical trials have shown that patients
with ischaemic stroke due to occlusion of a large intracranial blood vessel
benefit from endovascular thrombectomy. However, predicting outcome
of treatment in an individual patient remains a challenge. We propose a
novel deep learning approach to directly exploit multimodal data (clinical
metadata information, imaging data, and imaging biomarkers extracted
from images) to estimate the success of endovascular treatment. We in-
corporate an attention mechanism in our architecture to model global
feature inter-dependencies, both channel-wise and spatially. We perform
comparative experiments using unimodal and multimodal data, to pre-
dict functional outcome (modified Rankin Scale score, mRS) and achieve
0.75 AUC for dichotomised mRS scores and 0.35 classification accuracy
for individual mRS scores.
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1 Introduction
Acute stroke is the second most common cause of death worldwide [43] and
the fourth in the UK [39]. More than 80% of strokes are ischaemic [37], caused
by a blockage of a blood vessel in the brain by a blood clot, leading to lack of
oxygen and death of brain tissue. Mechanical thrombectomy, is the most effective
treatment for the most severe and potentially disabling ischaemic strokes, caused
by occlusion of large cerebral blood vessels. In this treatment, thrombi in the
large intracranial arteries are mechanically removed via an intra-arterial catheter
and blood flow is restored.
Recent randomised clinical trials have shown that patients treated with en-
dovascular thrombectomy (EVT) have a greatly increased chance of being inde-
pendent 3 months after stroke [16]. In clinical trials functional independence is
generally measured using the modified Rankin Scale score (mRS), ranging from
0 (no symptoms) through increasing levels of symptoms and dependency to 6
(death).
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Thrombectomy carries a risk of adverse effects, including brain haemorrhage
and a small risk of death. Treatment is therefore carried out according to the
treating clinicians judgement about the estimated risks and benefits for each
individual patient. The aim is to deploy all available information (i.e. imaging
and clinical data) to decide on the most favourable treatment option as soon as
possible, as treatment effect is strongly anchored on time to treatment.
Different clinical trials of thrombectomy have used different imaging methods
along with more or less stringent criteria for inclusion, and selecting the patients
most suitable for treatment remains a challenge. Estimating the potential success
of EVT would support clinical decision-making, improving access to treatment
for those who might benefit and potentially avoiding treatment where risks are
highest.
Over the last decade, there has been a rise in the popularity of deep learning
methods due to their promising success in various problems (i.e. image classifi-
cation, object detection and medical image analysis). Convolutional neural net-
works (CNNs) in particular, have been applied to numerous medical image anal-
ysis problems and have achieved state-of-the-art results on tasks such as brain
tumour segmentation [24] and disease prediction [34]. There have been numerous
attempts to apply machine and deep learning techniques in the area of automated
ischaemic stroke lesion detection, segmentation and prognosis [24,26,20], includ-
ing the Ischaemic Stroke Lesion Segmentation (ISLES)1 Challenge [29]. Most
of the studies have focused on either segmentation of stroke lesions on baseline
imaging or predicting tissue outcome from ‘baseline’ to ‘follow-up’ scans. Al-
though segmentation and detection of ischaemic stroke could assist the clinical-
decision process, it requires voxel-wise annotation of huge quantities of data
which is laborious and costly. Also, segmentation does not provide direct infor-
mation about the success rate of treatment.
Different imaging modalities are available for evaluation of stroke in the con-
text of thrombectomy treatment selection [13,2]. The most widely used and
available are non-contrast CT (NCCT) and CT angiography (CTA). The MR
CLEAN study [15] was the first randomised controlled trial to demonstrate the
effectiveness of thrombectomy for ischaemic stroke and used only NCCT and
CTA images. We have used the dataset from the MR CLEAN trial in this study.
In this paper, we propose a novel CNN architecture to process raw baseline
NCCT image volumes (the first scan when the patient was admitted to hospi-
tal) and clinical metadata to predict the functional outcome of EVT with either
dichotomised or individual mRS scores 3 months after treatment. Two attention
modules, spatial and channel attention, based on Squeeze and Excitation [21]
are used in our architecture which encourage the network to focus on impor-
tant regions and for more accurate outcome predictions. We explore pre-trained
networks and focal loss to handle class imbalance in our dataset.
To make more accurate treatment outcome predictions, it is important to
train our learning model with patients who have received treatment, as well as
those who have not. Therefore, note that in the rest of this paper, when we state
1 http://www.isles-challenge.org
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that a network is trained with 3D NCCT image volume only, clinical metadata
only, or fusion of both, each case also includes treatment information, defined as
a simple one-hot vector of whether a patient was randomized for EVT or not.
To the best our knowledge, there is no existing method that can predict
outcome of EVT from multimodal data, i.e. 3D NCCT volumes and clinical
metadata. The main contributions of our work are as follows. We introduce
a CNN architecture that is able to handle multimodal data, i.e. radiological
image and clinical metadata information, to estimate the degree of success if
EVT is performed. We integrate an attention mechanism in our architecture
to capture discriminatory features both spatially and channel-wise. Extensive
comparative experiments are conducted on different architectures, including a
CNN network [4], the encoder part of 3D U-Net [12] which is a popular network
in the medical image analysis community, and 3D ResNet networks with and
without pre-training from MedicalNet [10], to demonstrate the significance of
our proposed network. Our multimodal method obtains the best performance
in comparative experiments, with 0.75 AUC and 0.62 F1-score in dichotomous
mRS scores and 0.35 classification accuracy in individual mRS scores.
The rest of the paper is structured as follows. We review the related works
in Section 2 and review the MR CLEAN dataset and our preprocessing methods
in Section 3. In Section 4, we develop our proposed network and training meth-
ods. We explain our experimental set-up and discuss our comparative results in
Section 5. Finally, we provide our conclusion and future work in Section 6.
2 Related Works
Early approaches in automated stroke detection and segmentation have relied
on simple thresholding methods with standard statistical, correlation-based data
analysis, such as [31,9,36], region growing [36,7,17] and classical machine learn-
ing methods, such as random forest (RFs) [30,32,8] and support vector ma-
chines (SVMs) [28]. More recently, CNN-based approaches have proved increas-
ingly popular in solving the ischaemic stroke segmentation challenge, such as
[11,22,26,24,35,44]. Next, we categorise examples of existing works by the data
modality applied to automatic stroke detection and/or prediction.
Clinical Metadata Analysis – Many existing works for the prognosis of
stroke treatment are based on clinical data only, investigating machine learn-
ing methods, such as logistic regression (LR) [42,41,19], SVMs [3,5,40], RFs
[30,19,40], artificial neural networks (ANNs) [3,40] and deep neural networks
(DNNs) [19]. For example, Weimar et al. [42] and Kent et al. applied LR on
clinical metadata, such as patient demographics, NIHSS scores, diabetes, to pre-
dict the outcome of ischaemic stroke patients. Heo et al. [19] investigated and
compared the applicability of LR, RFs and DNNs on clinical data to predict
the outcome of the ischaemic stroke with a large cohort of 2604 patients They
found that DNNs performed best (at 0.88 AUC) on their dataset. Van et al.
[40] applied the Super Learner, an ensemble method that finds the optimally
weighted combination of predictions of the RF, ANN and SVM algorithms, to
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predict 3-months functional outcome after endovascular treatment. In Nishi et
al. [33], LR, RF and SVM were applied to clinical metadata, such as NIHSS
score, blood glucose level and the affected brain side to predict the outcome of
ischaemic stroke with large vessel occlusion before applying thrombectomy.
Image Data Analysis – There have been relatively few studies for out-
come of ischaemic stroke treatment using only imaging data. Maier et al. [30]
first trained a model to predict lesion outcomes from magnetic resonance imaging
(MRI) images by extracting statistical (10 percentile values, standard deviation,
variance) and shape (region area, perimeter, roundness) features from three re-
gions of interest (ROI) (core lesion, tissue around lesion and the rest of the
brain) based on lesion outcome probability maps. Then, they applied RFs to
predict ischaemic stroke outcome. Hilbert et al. [20] employed a ResNet model
which was trained with CTA images from the MR CLEAN Registry [23] dataset.
They determined the functional outcome from a single 2D image, obtained from
a maximum intensity projection of a 3D CTA volume (of the patient). They
predicted good or bad outcomes only rather than more fine-grained levels of
functional outcomes.
Multimodal Data Analysis – The works in this category, in one way
or another, have applied both imaging data of various modalities and clinical
metadata for their decision-making process. SVMs were employed by Bentley et
al. [5] to distinguish between conditions favourable to thrombolysis treatment
or not, based on raw unenhanced CT images and NIHSS scores. Forkert et al.
[14] applied 12 SVM models in predicting functional outcome at 30 days after
treatment. They used values of lesion overlap from different brain regions and
stroke laterality alongside other clinical metadata, such as NIHSS and patient
age. Choi et al. [11] proposed a CNN model that processed 3D MRI diffusion and
perfusion imaging and clinical metadata information, such as time since stroke,
time to treatment, and thrombolysis in cerebral infarction, to predict treatment
outcome. Additionally, they combined their CNN model with logistic regression
on the clinical metadata alone, as an ensemble model for final prediction. Bacchi
et al. [4] predicted binary outcomes of thrombolysis treatment using a dataset
of 204 patients with NCCT image volumes and related clinical data (e.g. age,
gender, blood pressure, NIHSS scores). Their best performing model (0.74 accu-
racy, 0.69 it F1-score, 0.75 AUC) was a combination of CNN and ANN networks
that were trained on both NCCT image volumes and clinical metadata.
3 Data & Preprocessing
Other than the comprehensive MR CLEAN Trial dataset2 used in this work,
there are no other publicly available datasets that contain both image, NCCT im-
age volumes and metadata of patients treated for ischaemic stroke. MR CLEAN
was a randomised, clinical trial of intra-arterial treatment and usual care versus
usual care in patients with a proximal arterial occlusion in the anterior circu-
lation treated within 6 hours of symptom onset. Five hundred patients (233
2 https://www.mrclean-trial.org/home.html
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assigned to EVT and 267 to usual care) were treated in 16 medical centres in
the Netherlands. The dataset includes a baseline (i.e., the first scan when the
patient was admitted to hospital) NCCT and CTA (for all 500 patients), 24-hour
follow-up NCCT and CTA scans (for 394 patients), and additionally a 1-week
follow-up NCCT scan (for 358 patients). An example of ischaemic changes on
NCCT following a stroke for this timeline (admission, 24-hours, 1 week) can
be seen in Fig.1. Additionally, MR CLEAN dataset contains clinical metadata
information on its 500 patients, consisting of 90 features, such as patient de-
mographics (age, gender), medical history and stroke scores (NIHSS), imaging
biomarkers (ASPECT) and outcome data mRS. For more detailed information
about the dataset, we refer the reader to the MR CLEAN study protocol [6,15].
(a) on hospital admission (b) 24-hr follow-up (c) 1-week follow-up
Fig. 1. Example Stroke NCCT scans (from MR CLEAN), a) first scan when the patient
was admitted to hospital, b) 24 hour follow-up scan c) 1-week follow-up scan.
There are various acquisition protocols of the NCCT scans in MR CLEAN
due to it being a multi-centre dataset. Through preprocessing, we reduce some
of this variation, to allow our learning network to deal with the same standard
input and smaller image size. First, all the scans are re-sampled to the same
voxel size of 1x1x5mm3 followed by clipping the intensity range between 40 to
100 HU. Then, we crop unnecessary non-brain regions to generate images of
size 32x192x192. Also, due to scarce data and to account for variations, data
augmentations such as horizontal/vertical flip, rotations, elastic deformations
and Gaussian noise are applied (for the network training stage only). The image
voxels are finally normalised to zero mean and one standard deviation.
4 Proposed Method
We now present our proposed multimodal network to predict the functional out-
come for EVT at multiple levels of the mRS score. We also explain the methods
we used to overcome class imbalance in the dataset, and outline the implemen-
tation details of our methods and experiments.
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Fig. 2. Overview of our model. cSE: channel squeeze and excitation, sCE: spatial
squeeze and excitation, k is kernel size, s is stride size and L is focal loss.
In order to replicate what a clinician would consider, we use multimodal data,
i.e. NCCT volumes and clinical metadata. In the case of the image volumes,
during training, we additionally incorporate a one-hot vector for treatment in-
formation only, indicating whether the patient was treated with EVT or not. For
clinical metadata, we use patient demographics, medical history, treatment infor-
mation, radiological image biomarkers (i.e. ASPECT score, occlusion, collateral
score and symptom side) and medical status/records (hypertension, glucose level
etc.) at time of admission to hospital. In the proposed method, we extract NCCT
volume features in our image feature encoding block (IFE), which later in the ex-
periments section, we compare against the approach in Bacchi et al. [4], a U-Net
encoder, and variations on ResNet. Our image volume features are then com-
bined with metadata information in our image and metadata fusion block (IMF)
for final mRS prediction. An overview of the proposed network architecture is
presented in Fig. 2.
Our outcome prediction of treatment is formulated as follows. Let Q =
{(Xi,Mi, yi)}Ni=1, be the training set of N patients, where Xi ∈ R1xDxWxH
denotes a 3D NCCT scan with D slices of height and width H and W respec-
tively, Mi ∈ R1xV represents a metadata information vector of size V with V = 2
when Mi is only treatment information and V = 52 when Mi is clinical metadata
information, and finally, yi ∈ {0, . . . , C − 1} corresponds to the ith label from C
classes, with C = 2 when the mRS score is dichotomised, and C = 7 otherwise.
IFE module – We need to extract local and global features from 3D volumes
to make robust mRS predictions. To achieve this, we apply 3D convolution blocks
to extract low and high level features, followed by squeeze & excitation (SE)
modules [21,38] that model global feature inter-dependencies both channel-wise
and spatially (see cSE and sSE blocks in Fig. 2). Therefore, our network is
encouraged to focus on important information through soft self-attention to learn
more representative features at minimal computational cost.
The IFE module processes an input volume Xi with three conv blocks, each
containing a 3D convolutional layer with a 3 × 3 × 3 kernel size, followed by
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instance normalisation and LeakyRelu activation. The first two blocks also apply
a downsampling layer with a strided-convolution. We use instance normalisation
over batch normalisation to be data frugal with memory requirements given our
3D data, and because a small batch size can lead to incorrect batch statistics
which would decrease the model performance. Liu et al. [27] have also recently
reported on the benefits of instance normalisation over batch normalisation for
3D medical image processing.
After applying the channel-wise cSE and spatial sSE attentional blocks to the
high-level features from our final conv block, we add these recalibrated feature
maps to the original high-level feature maps element-wise. Then, a global average
pooling (GAP in Fig. 2) on the aggregated matrix, generates our final image
features, X˜i, in preparation for fusion in the IMF module.
IMF module – This module applies a fully connected layer to the image
features X˜i and the metadata information Mi, followed by a ReLU activation
function, to generate encoded image volume features, FX˜i ∈ R1xJ where J is
the feature vector size and metadata features, FMi ∈ R1xL with L ≤ J . These
features are then concatenated to become the output of the IMF module, such
that
X˜i = IFE(Xi) ,
FX˜i,Mi = IMF(FX˜i , FMi) .
(1)
Generating the mRS score – The classification stage of the proposed
network processes the fused features through a FC layer with C outputs. Finally,
a Softmax function is applied to the outputs to generate a probability vector of
C classes, pi = {pci}C−1c=0 , where pi is the predicted mRS probability scores for
the C classes, i.e.
pi = softmax(f(FX˜i,Mi)) , (2)
and the predicted mRS score is
mRS score = arg max
c
(pci ). (3)
Class Imbalance – Class imbalance leads to a bias toward the majority
class in training data, and in the MR CLEAN Trial data, the distribution of
the classes are highly imbalanced, i.e. {7, 36, 84, 87, 133, 45, 108} patients for
mRS scores 0 to 6, respectively. To deal with this data shortage, we use focal
loss [25,1] to generate an adaptive weighting loss function, such that
LFL = −
N∑
i=1
αiyi(1− pi)γ log(pi) , (4)
where αi is a prefixed value between 0 and 1 to balance the positive and negative
labelled samples. The focal intensity factor is γ where if γ = 0 and αi = 1, the
loss becomes a standard cross entropy loss.
Furthermore, as adopted in [29,20], we train our networks and report our
results both for all classes, and for groups of classes (i.e. mRS scores 0 − 2
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as good outcome and mRS scores 3 − 6 as undesirable outcome) which helps
mitigate further for the class imbalance problem.
DNN for Clinical Metadata Only – We also build a DNN for training
clinical metadata information only to compare its predictive value with models
that utilised image information. This DNN consists of two FC layers with hidden
units of 128 and C (2 or 7) number of output classes. We use dropout after the
first FC layer for regularisation.
5 Experiments and Results
We purposed 80% of our data (400 patients) for training and 20% (100 patients)
for testing. The full range of clinical metadata used in our experiments was the
same as that in [40].
We evaluated the performance of our proposed network against other data
and network configurations (in place of our IFE module). These are, (i) ResNet-
18 and ResNet-34 as 3D implementations of ResNet [18], with their weights set
by He normal initialisation, (ii) ResNet-18preT and ResNet-34preT using pre-
trained weights from MedicalNet [10] which were frozen (conv1 to layer4 ) and
then our IMF module was fine-tuned during training, (iii) U-NetEncoder, i.e.
the encoder part of 3D U-Net [12] initialised with He normal, (iv) ClinicDNN,
our own simple DNN applied on our clinical metadata only, and finally (v) the
3D CNN model from Bacchi et al. [4], trained from scratch, which generated
mRS scores for thrombolysis (see Section 2 for details).
The networks in all our experiments were consigned with the same parameter
values for training. We set the batch size to 8 and number of epochs to 300 with
early stopping if the network did not improve after 50 epochs. We used SGD
with a momentum of 0.9 as the optimizer. The learning rate was initialised to
0.00003, determined empirically and decreased with cosine annealing scheduler.
The experiments were performed on a single GPU (NVIDIA TITAN V 12GB)
using PyTorch.
We present two main experiments. In the first, Exp.A, we dichotomised the
mRS scores into C = 2 classes, good outcome (mRS = 0− 2) and bad outcome
(mRS = 3− 6) of ischaemic stroke treatment. In Exp.B, we used all mRS scores
individually for classification as C = 7 classes (mRS = 0, 1, 2, 3, 4, 5, 6). We
trained each network both on 3D NCCT volumes only and 3D NCCT volumes
with clinical metadata, except for our simple ClinicDNN network which was
trained only on clinical metadata.
Exp. A - Dichotomous mRS scores – The performance of the various
models is compared by classification Accuracy, F1-score and Area Under ROC
Curve (AUC) and their results are reported in Table 1. When training was
based on 3D NCCT volumes only, our proposed model performed best, with
0.75 Accuracy , 0.46 F1-score and 0.67 AUC, while other networks performed
significantly worse in F1-score and AUC.
Our simple ClinicDNN network achieved 10% better in F1-score and 3%
better in AUC than our model using 3D NCCT volumes only, but this can be
Prediction of Thrombectomy Functional Outcomes using Multimodal Data 9
Table 1. Results for dichotomised mRS score (0 − 2 and 3 − 6) when trained on 3D
volumes only, clinical metadata only and combination of 3D volumes and metadata.
Models Accuracy F1-score AUC
3D NCCT volume only
ResNet-18 0.74 0.00 0.58
ResNet-18preT [10] 0.74 0.00 0.58
ResNet-34 0.75 0.07 0.47
ResNet-34preT [10] 0.75 0.07 0.59
U-NetEncoder [12] 0.74 0.43 0.65
Bacchi et al. [4] 0.74 0.00 0.50
Proposed Method 0.75 0.46 0.67
Clinical metadata only Proposed ClinicDNN 0.66 0.56 0.70
3D NCCT volume and
Clinical metadata
ResNet-18 0.74 0.00 0.59
ResNet-18preT [10] 0.73 0.00 0.58
ResNet-34 0.74 0.00 0.52
ResNet-34preT [10] 0.70 0.35 0.63
U-NetEncoder [12] 0.75 0.59 0.73
Bacchi et al. [4] 0.78 0.42 0.74
Proposed Method 0.77 0.62 0.75
attributed to the radiological biomarkers, determined by expert radiologists from
3D NCCT scans, that were included in the clinical metadata.
The leading results were obtained when combined 3D NCCT scans and clin-
ical metadata were deployed for training. While Bacchi et al. [4]’s model per-
formed best in classification accuracy at 0.78, our proposed method produced
the best results in F1-score, increasing from 0.46 to 0.62, and in AUC, climbing
from 0.67 to 0.75, compared to when using 3D volume data only.
Exp. B - Individual mRS scores – In this experiment, we predict each
mRS score - 7 classes - individually. This means the expected accuracy would
drop due to the scarcity of data in some classes, despite our class-imbalance
mitigations, and since the groundtruth labels may not be precisely accurate
given clinicians’ judgements. Hence, we use both classification Accuracy and 1-
Nearest Accuracy as performance comparison measures where the latter is the
percentage of samples either correctly classified or classified as the one nearest
class (i.e. correct if yi − 1 ≤ arg max(pi) ≤ yi + 1). This allows a measure for a
reasonable prediction of EVT outcome.
The results of this experiment are reported in Table 2. Our proposed method
performed best in both comparison metrics compared to other methods, albeit
when using different data types. Similar to Exp.A, the performance of many of
the models benefited from combining imaging and clinical metadata informa-
tion. However, our proposed model’s performance decreased in the 1-Nearest
Accuracy measure when using multimodal data, since for individual mRS score
classification, the predictions were spread across classes instead of accumulating
around the majority ones (mRS 4 and 6).
Ablation Study – Table 3 demonstrates the importance of the attention
modules, cSE and sSE, when they are omitted from our proposed method. The
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Table 2. Results for individual mRS scores when models trained on 3D volumes only,
clinical metadata only and combination of 3D volumes and clinical metadata.
Models Accuracy 1-Nearest Acc.
3D NCCT volume only
ResNet-18 0.30 0.63
ResNet-18preT [10] 0.25 0.57
ResNet-34 0.29 0.60
ResNet-34preT [10] 0.31 0.61
U-NetEncoder [12] 0.32 0.59
Bacchi et al. [4] 0.27 0.56
Proposed method 0.32 0.66
Clinical metadata only Proposed ClinicDNN 0.29 0.64
3D NCCT volume and
Clinical metadata
ResNet-18 0.31 0.64
ResNet-18preT [10] 0.31 0.62
ResNet-34 0.29 0.63
ResNet-34preT [10] 0.32 0.55
U-NetEncoder [12] 0.32 0.60
Bacchi et al. [4] 0.24 0.57
Proposed method 0.35 0.63
Table 3. Ablation study results when attention modules are not deployed.
Dichotomised mRS Individual mRS
Accuracy F1-score AUC Accuracy 1-Nearest Acc.
3D NCCT volume only 0.67 0.41 0.62 0.27 0.63
3D NCCT volume and
Clinical metadata
0.71 0.57 0.72 0.29 0.60
performance of our model decreased for example, in classification accuracy from
0.77 down to 0.71, in F1-score from 0.62 down to 0.57 and in AUC from 0.75
down to 0.72, in the case of dichotomised mRS scores and combination of imaging
and clinical metadata information.
6 Conclusions
In this study, we presented a novel approach to predicting functional outcome
of ischaemic stroke treatment from multimodal data. We added an attention
mechanism in our architecture to extract representative features both spatially
and channel-wise. In both Exp.A and Exp.B, our proposed method outperformed
other methods, with 0.62 F1-score and 0.75 AUC and in dichotomous mRS scores
and 0.35 classification Accuracy in individual mRS scores, leading us to conclude
that combining clinical metadata information with 3D imaging information and
attention modules increases performance.
The results also demonstrate that a well-designed shallower network can per-
form better than deep networks for this specific task, given the architectures of
our proposed model and Bacchi et al. (in Exp.A) against the ResNet models,
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while the deep ResNet models perform better than Bacchi et al. in Exp.B, po-
tentially due to their better generalisation in the face of class imbalance.
For future work, we plan to investigate the class imbalance issue more elab-
orately, while collecting more data for the minority classes. We aim to explore
other data fusion strategies, e.g. adaptive fusion and late fusion. Given sufficient
data, we plan to also analyse temporal changes in stroke regions in 3D NCCT
follow-up scans for better prediction of functional outcome of treatment.
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